40 likes | 108 Views
Supplemental file 3 Overall survivals of the entire cohort of patients. 100. 100. P = 0.011. P = 0.019. 80. 80. Nasal. Normal ALT. 60. 60. Cumulative Survival (%). Cumulative Survival (%). Disseminated. 40. 40. Elevated ALT. 20. 20. Non – nasal. 80. 80. 20. 20. 40. 40.
E N D
Supplemental file 3 Overall survivals of the entire cohort of patients 100 100 P = 0.011 P = 0.019 80 80 Nasal Normal ALT 60 60 Cumulative Survival (%) Cumulative Survival (%) Disseminated 40 40 Elevated ALT 20 20 Non – nasal 80 80 20 20 40 40 60 60 100 100 Overall Survival (months) Overall Survival (months) A B
100 100 P < 0.001 P = 0.003 80 80 60 60 Non - leukemic Cumulative Survival (%) Cumulative Survival (%) BM negative 40 40 Leukemic BM positive 20 20 80 80 20 20 40 40 60 60 100 100 Overall Survival (months) Overall Survival (months) C D
100 100 P < 0.001 IPI = 0 Stage I 80 80 IPI = 1 60 60 Stage II Cumulative Survival (%) Cumulative Survival (%) P = 0.001 40 40 IPI = 3 IPI = 2 IPI = 5 Stage IV 20 20 IPI = 4 80 80 20 20 40 40 60 60 100 100 Overall Survival (months) Overall Survival (months) E F
100 100 KIPI = 0 EBV group A KIPI = 1 80 80 KIPI = 2 60 60 Cumulative Survival (%) Cumulative Survival (%) P < 0.001 KIPI = 3 40 40 P < 0.001 EBV group C 20 20 KIPI = 4 EBV group B 80 80 20 20 40 40 60 60 100 100 Overall Survival (months) Overall Survival (months) G H